Methocarbamol and Lipofen drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported only by a few people who take Methocarbamol and Lipofen together.
The phase IV clinical study analyzes what interactions people who take Methocarbamol and Lipofen have. It is created by eHealthMe based on reports of 3 people who take the same drugs from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
3 people who take Methocarbamol and Lipofen together, and have interactions are studied.
What is Methocarbamol?
Methocarbamol has active ingredients of methocarbamol. It is often used in muscle spasms. eHealthMe is studying from 14,418 Methocarbamol users for its effectiveness, alternative drugs and more.
What is Lipofen?
Lipofen has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 232 Lipofen users for its effectiveness, alternative drugs and more.
Number of Methocarbamol and Lipofen reports submitted per year:

Common Methocarbamol and Lipofen drug interactions by gender *:
female:
- Urticaria
- Abdominal pain
- Arthralgia
- Cough
- Diarrhoea
- Haematochezia
- Headache
- Nasal congestion
- Oropharyngeal pain
- Pyrexia
male:
n/a
Common Methocarbamol and Lipofen drug interactions by age *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Urticaria
60+:
- Abdominal pain
- Arthralgia
- Cough
- Diarrhoea
- Haematochezia
- Headache
- Nasal congestion
- Oropharyngeal pain
- Pyrexia
* Approximation only. Some reports may have incomplete information.
Do you take Methocarbamol and Lipofen?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Alternative drugs to, pros and cons of the 2 drugs:
- Methocarbamol (14,418 reports)
- Lipofen (232 reports)
Browse all drug interactions of Methocarbamol and Lipofen:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Methocarbamol side effects:
- Pain: 1,128 reports
- Fatigue (feeling of tiredness): 967 reports
- Drug ineffective: 916 reports
- Chronic kidney disease: 838 reports
- Stress and anxiety: 820 reports
- Headache (pain in head): 743 reports
- High blood pressure: 643 reports
Browse all side effects of Methocarbamol:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Methocarbamol interactions:
- Methocarbamol and Gabapentin: 3,574 reports
- Methocarbamol and Tramadol: 2,464 reports
- Methocarbamol and Omeprazole: 2,120 reports
- Methocarbamol and Aspirin: 2,112 reports
- Methocarbamol and Lisinopril: 1,934 reports
- Methocarbamol and Profen: 1,823 reports
- Methocarbamol and Ibu: 1,821 reports
- Methocarbamol and Ibuprofen: 1,806 reports
- Methocarbamol and Prednisone: 1,776 reports
- Methocarbamol and Vitamin d: 1,694 reports
Browse all interactions between Methocarbamol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on methocarbamol and fenofibrate (the active ingredients of Methocarbamol and Lipofen, respectively), and Methocarbamol and Lipofen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Methocarbamol and Lipofen.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Mepron and Fentanyl drug interaction - 2 seconds ago
- Naloxone and Heparin-Induced Thrombocytopenia - 4 seconds ago
- Valsartan and Bone Lesion - 6 seconds ago
- Flomax and Investigation Abnormal - 14 seconds ago
- Myrbetriq and Klebsiella Test Positive - 16 seconds ago
- Ganciclovir and Hepatic Failure - 18 seconds ago
- Zometa and Parathyroid Disorder - 21 seconds ago
- Ezetimibe and Xarelto drug interaction - 22 seconds ago
- Vitamin D and Blood Albumin Decreased - 23 seconds ago
- Lisinopril and Viral Infection - 24 seconds ago